HIV-1 reverse transcriptase discriminates against non-self tRNA primers

Journal of Molecular Biology

Volumn 264, Issue 2, 1996, Pages 243-254

  Oude Essink, Belinda B ^a   Das, Atze T ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

HIV 1 retrovirus; Primer binding site; Reverse transcription; tRNA primer

Indexed keywords

ISOLEUCINE TRANSFER RNA; LYSINE TRANSFER RNA; PHENYLALANINE TRANSFER RNA; PRIMER RNA; RNA DIRECTED DNA POLYMERASE; TRANSFER RNA;

ARTICLE; DNA SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RNA TRANSCRIPTION; VIRION; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0030606301     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0638     Document Type: Article

References (54)

1. Aiyar, A., Cobrinik, D., Ge, Z., Kung, H. J. & Leis, J. (1992). Interaction between retroviral U5 RNA and the TYC loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription. J. Virol. 66, 2464-2472.
2. Aiyar, A., Ge, Z. & Leis, J. (1994). A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J. Virol. 68, 611-618.
3. Arts, E. J. & Wainberg, M. A. (1994). Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription. Antimicrob. Agents Chemother. 38, 1008-1016.
4. Arts, E. J., Li, X., Gu, Z., Kleiman, L., Parniak, M. A. & Wainberg, M. A. (1994a). Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction. J. Biol. Chem. 269, 14672-14680.
5. Arts, E. J., Mak, J., Kleiman, L. & Wainberg, M. A. (1994b). DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity. J. Gen. Virol. 75, 1605-1613.
6. Arts, E. J., Ghosh, M., Jacques, P. S., Ehresmann, B. & Le Grice, S. F. J. (1996a). Restoration of tRNALys,3-primed (-)-strand DNA synthesis to an HIV-1 reverse transcriptase mutant with extended tRNAs. J. Biol. Chem. 271, 9054-9061.
7. Arts, E. J., Marois, J.-P., Gu, Z., Le Grice, S. F. J. & Wainberg, M. A. (1996b). Effects of 3′-deoxynucleoside 5′-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription. J. Virol. 70, 712-720.
8. Back, N. K. T., Nijhuis, M., Keulen, W., Boucher, C. A. B., Oude Essink, B. B., van Kuilenburg, A. B. P., Van Gennip, A. H. & Berkhout, B. (1996). Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J. 15. 4040-4049.
9. Baltimore, D. (1970). Viral RNA-dependent DNA polymerase RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature, 226, 1209-1211.
10. Barat, C., Lullien, V., Schatz, O., Keith, G., Mugeyre, M. T., Grüninger-Leitch, F., Barré-Sinoussi, F., LeGrice, S. F. J. & Darlix, J. L. (1989). HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO J. 11, 3279-3285.
11. Barat, C., Le Grice, S. F. & Darlix, J. L. (1991). Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNA(Lys,3). Nucl. Acids Res. 19, 751-757.
12. Barat, C., Schatz, O., Le Grice, S. & Darlix, J. L. (1993). Analysis of the interactions of HIV1 replication primer tRNA(Lys, 3) with nucleocapsid protein and reverse transcriptase. J. Mol. Biol. 231, 185-190.
13. Berkhout, B. (1996). Structure and function of the human immunodeficiency virus leader RNA. In Progress in Nucleic Acid Research and Molecular Biology (Cohn, W. E. & Moldave, K., eds), vol. 54, 1-34. Academic Press, Inc. San Diego.
14. Berkhout, B. & Klaver, B. (1993). In vivo selection of randomly mutated retroviral genomes. Nucl. Acids Res. 21, 5020-5024.
15. Berkhout, B., Oude Essink, B. B. & Schoneveld, I. (1993). In vitro dimerization of HIV-2 leader RNA in the absence of PuGGAPuA motifs. FASEB J. 7, 181-187.
16. Berkhout, B. & Schoneveld, I. (1993). Secondary structure of the HIV-2 leader RNA comprising the tRNA-primer binding site. Nucl. Acids Res. 21, 1171-1178.
17. Cobrinik, D., Aiyar, A., Ge, Z., Katzman, M., Huang, H. & Leis, J. (1991). Overlapping retrovirus U5 sequence elements are required for efficient integration and initiation of reverse transcription. Structure of the retroviral genome. J. Virol. 65, 3864-3872.
18. Coffin, J. (1984). In RNA Tumor Viruses (Weiss, R., Teich, N., Varmus, H. & Coffin, J., eds), 4th edit., pp. 261-368, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
19. 3Lys. J. Virol. 69, 3090-3097.
20. De Rocquigny, H., Gabus, C., Vincent, A., Fournie-Zaluski, M.-C, Roques, B. & Darlix, J.-L. (1992). Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl Acad. Sci. USA, 89, 6472-6476.
21. Hu, W.-S. & Temin, H. M. (1990). Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc. Natl Acad. Sci. USA, 87, 1556-1560.
22. Huber, H. E., McCoy, J. M., Seehra, J. S. & Richardson, C. C. (1989). Human immunodeficiency virus 1 reverse transcriptase; Template binding, processivity, strand displacement synthesis & template switching. J. Biol. Chem. 264, 4669-4678.
23. Lys3 modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription. J. Biol. Chem. 268, 25269-25272.
24. 3Lys (template/primer). J. Mol. Biol. 247, 236-250.
25. Lys3. EMBO J. 15, 917-924.
26. Jiang, M., Mak, J., Ladha, A., Cohen, E., Klein, M., Rovinski, B. & Kleiman, L. (1993). Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J. Virol. 67, 3246-3253.
27. Kaplan, A. H., Krogstad, P., Kempf, D. J., Norbeck, D. W. & Swanstrom, R. (1994). Human immunodeficiency virus type 1 virions composed of unprocessed gag and gag-pol precursors are capable of reverse transcribing viral genomic RNA. Antimicrob. Agents Chemother. 12, 2929-2933.
28. Khan, R. & Giedroc, D. P. (1992). Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA. J. Biol. Chem. 267, 6689-6695.
29. Lapadat-Tapolsky, M., Pernelle, C., Borie, C. & Darlix, J.-L. (1995). Analysis of the nucleic acid annealing activities of nucleocapsid protein from HIV-1. Nucl. Acids Res. 23, 2434-2441.
30. Leis, J., Aiyar, A. & Cobrinik, D. (1993). Regulation of initiation of reverse transcription of retroviruses. In Reverse Transcriptase (Skalka, A. M. & Goff, S. P., eds), pp. 33-48, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
31. Li, X., Mak, J., Arts, E. J., Gu, Z., Kleiman, L., Wainberg, M. A. & Parniak, M. A. (1994). Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication. J. Virol. 68, 6198-6206.
32. Lori, F., Veronese, F. D. M., De Vico, A. L., Lusso, P., Reitz, M. S., Jr & Gallo, R. C. (1992). Viral DNA carried by human immunodeficiency virus type 1 virions. J. Virol. 66, 5067-5074.
33. Mak, J., Jiang, M., Wainberg, M. A., Hammarskjold, M. L., Rekosh, D. & Kleiman, L. (1994). Role of Pr160gagpol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles. J. Virol. 68, 2065-2072.
34. Mely, Y., De Rocquigny, H., Sorinas-Jimeno, M., Keith, G., Roques, B. P., Marquet, R. & Gerard, D. (1995). Binding of the HIV-1 nucleocapsid protein to the primer tRNALys3, in vitro, is essentially not specific. J. Biol. Chem. 270, 1650-1656.
35. Meyerhans, A., Vartanian, J.-P., Hultgren, C., Plikat, U., Karlsson, A., Wang, L., Eriksson, S. & Wain-Hobson, S. (1994). Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J. Virol. 68, 535-540.
36. Mishima, Y. & Steitz, J. A. (1995). Site-specific cross-linking of 4-thiouridine-modified human tRNALys3 to reverse transcriptase from human immunodeficiency virus type 1. EMBO J. 14, 2679-2687.
37. O'Brien, W. A., Namazi, A., Kalhor, H., Mao, S.-H., Zack, J. A. & Chen, I. S. Y. (1994). Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol. 68, 1258-1263.
38. Oude Essink, B. B., Das, A. T. & Berkhout, B. (1995). Structural requirements for the binding of tRNA Lys3 to reverse transcriptase of the human immunodeficiency virus type 1. J. Biol. Chem. 270, 23867-23874.
39. Peden, K. W. C. & Martin, M. A. (1996). Virological and molecular genetic techniques for studies of established H2V isolates. In HIV, a Practical Approach (Karn, J., ed.), pp. 21-25, IRL Press at Oxford University Press, Oxford, New York and Tokyo.
40. ELI. Virology, 185, 661-672.
41. Reardon, J. E. & Miller, W. H. (1990). Human immunodeficiency virus reverse transcriptase. J. Biol. Chem. 265, 20302-20307.
42. Richter-Cook, N. J., Howard, K. J., Cirino, N. M., Wohrl, B. M. & Le Grice, S. F. (1992). Interaction of tRNA(Lys-3) with multiple forms of human immunodeficiency virus reverse transcriptase. J. Biol. Chem. 267, 15952-15957.
43. Sarih-Cottin, L., Bordier, B., Musier-Forsyth, K. Andreola, M. L., Barr, P. J. & Litvak, S. (1992). Preferential interaction of human immunodeficiency virus reverse transcriptase with two regions of primer tRNA(Lys) as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotides. J. Mol. Biol. 226, 1-6.
44. Temin, H. M. & Mizutani, S. (1970). Viral RNA-dependent DNA polymerase in virions of rous sarcoma virus. Nature, 226, 1211-1213.
45. Trono, D. (1992). Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J. Virol. 66, 4893-4900.
46. Varmus, H. & Swanstrom, R. (1984). Replication of retroviruses. In RNA Tumor Viruses (Weiss, R., Teich, N., Varmus, H. & Coffin, J., eds), 2nd edit., pp. 369-512, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
47. Wakefield, J. K., Rhim, H. & Morrow, C. D. (1994). Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site. J. Virol. 68, 1605-1614.
48. Wakefield, J. K., Wolf, A. G. & Morrow, C. D. (1995). Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNALys3. J. Virol. 69, 6021-6029.
49. Wakefield, J. K., Kang, S.-M. & Morrow, C. D. (1996). Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNAHis. J. Virol. 70, 966-975.
50. Wohrl, B. M., Ehresmann, B., Keith, G. & Le Grice, S. F. (1993). Nuclease footprinting of human immunodeficiency virus reverse transcriptase/ tRNA(Lys-3) complexes. J. Biol. Chem. 268, 13617-13624.
51. Yu, S. F., Baldwin, D. N., Gwynn, S. R., Yendapalli, S. & Linial, M. L. (1996). Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science, 271, 1579-1582.
52. Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A. & Chen, I. S. Y. (1990). HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell, 61, 213-222.
53. Zhang, H., Zhang, Y., Spicer, T. P., Abbott, L. Z., Abbott, M. & Poiesz, B. J. (1993). Reverse transcription takes place within extracellular HIV-1 virions: potential biological significance. AIDS Res. Hum. Retroviruses, 9, 1287-1296.
54. Zhang, H., Dornadula, G., Wu, Y., Havlir, D., Richman, D. D. & Pomerantz, R. J. (1996). Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo. J. Virol. 70, 628-634.